DPI Research publishes the United States Human Vaccines Market research study that looks at the industry, major market trends, and historical and expected market data. A market overview, as well as definitions and applications, are included in the study.

2. Amid the COVID-19 crisis,
the United States human vaccines
market is poised to grow by US$
31,517 million by 2028, accelerating
at a CAGR of 7% during the forecast
period.
MARKET UPDATE

3. MARKET DESCRIPTION
The Prominent Factors that are Expected to Contribute
to the Growth of the United States Human Vaccines
Market During the Forecast Period:
✓Increased Disease Awareness
✓Approval/launches of the New Vaccines
✓Rising Focus on Immunization Programs
✓Increasing Investments and Government
Support for the Vaccines Development

4. MARKET DESCRIPTION
After conducting thorough research on the historical and current growth parameters, the
growth prospects of the United States human vaccines market are obtained with maximum
precision.
This new 2022 market report provides a holistic analysis of the entire United States human
vaccines market. The report offers the most up–to–date industry data on the actual market
situation and future outlook for the United States’ human vaccines market. The report also
provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative
forecast to 2028 covering key market aspects like market value, analysis, and trends for
human vaccines in the United States. A comprehensive analysis has been done on market
share with the percentage of all the 45 human vaccines brand used in the United States.

5. MARKET DESCRIPTION
The report contains a deep analysis of the United States human vaccines
market size in terms of value. The report provides a clear insight into
current and future developments of the United States vaccines market.
The report also explores the detailed analysis, insights of the top 45
vaccines market assessment in the United States from 2018 to 2021, and
forecasts to 2028. The report also details the latest information about the
vaccine’s pricing analysis, insights, and trends, and the regulatory
framework of the United States human vaccines market.

6. REPORTS DELIVERS
• Comprehensive Research Methodology of
the United States Human Vaccines Market
First feature
• Insights about Market Determinants that
are Stimulating the United States Human
Vaccines Market
Second
feature
• To Analyse the Historical Growth in the
Market Size of the United States Human
Vaccines Market from 2018 to 2021
Third feature

7. INDUSTRY OVERVIEW
This slide is 100% editable. Adapt
it to your needs and capture your
audience's attention.
49%
This slide is 100% editable. Adapt
it to your needs and capture your
audience's attention.
91%
This slide is 100% editable. Adapt
it to your needs and capture your
audience's attention.
21,545
31,517
Million
US$
United States Human Vaccines Market, 2022 - 2028
2028
2022

8. COMPETITIVE ANALYSIS
The Key Player for the United States Human Vaccines Market are Listed Below:
✓Pfizer
✓Merck
✓Sanofi Pasteur
✓Seqirus (CSL Limited)
✓AstraZeneca
✓GlaxoSmithKline (GSK)
✓Emergent Biosolutions
✓Dynavax Technologies Corporation

9. KEY QUESTIONS ANSWERED IN THIS REPORT:
 What is the current scenario of the United States human vaccines
market?
 What is the total market size and forecast (until 2028) of the United
States human vaccines market?
 How big is the United States human vaccines market?
 At what CAGR is the U.S. human vaccines market projected to grow in
the forecast period (2022-2028)?
 What are the leading human vaccines? What are their revenue potentials
to 2028?
 Which human vaccine brand provides the highest market share?

10. THANKYOU
MARIA RAI
+91 7667648693
SALES@DPIRESEARCH.COM
DPI RESEARCH